You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維康藥業(300878.SZ):與北京盈科瑞簽署戰略合作協議暨1.1類中藥創新藥項目合作
格隆匯 06-30 21:44

格隆匯6月30日丨維康藥業(300878.SZ)公佈,2021630日,公司與北京盈科瑞創新醫藥股份有限公司(“北京盈科瑞”)簽署了《戰略合作協議》、《“1.1類中藥創新藥參丹通腦滴丸”技術轉讓合同》,與盈科瑞(珠海)創新醫藥製造有限公司(“珠海盈科瑞)簽署了《“1.1類中藥創新藥黃甲軟肝顆粒”技術轉讓合同》,與盈科瑞(天津)創新醫藥研究有限公(“天津盈科瑞”)簽署了《“温經湯”技術開發(委託)合同》、“二冬湯”技術開發(委託)合同》、《“養胃湯”技術開發(委託)合同》、《“濟川煎”技術開發(委託)合同》、《“三甲復脈湯”技術開發(委託)合同》、《“五味消毒飲”技術開發(委託)合同》。

次公司與北京盈科瑞簽署戰略合作協議和1.1類中藥創新藥技術轉讓合同,與珠海盈科瑞簽署1.1類中藥創新藥技術轉讓合同,與天津盈科瑞簽署簽署6個經典名方的技術開發(委託)合同,有利於促進各方技術、產品與服務的延伸和發展,符合公司長期發展戰略,有利於增強公司的藥物研發能力,提升藥品臨牀試驗能力同時也有利於增強公司的持續盈利能力和整體抗風險能力,符合公司發展戰略及全體股東的利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account